Lydia Abad-Franch
Fortune : 1 M $ au 31/05/2026
Fortune : 1 M $ au 31/05/2026
Lydia Abad-Franch is currently Chief Medical Officer, Head-Research & Development at Swedish Orphan Biovitrum AB since 2023.
Formerly, Dr. Abad-Franch was Senior Director-Global Medical Affairs at Takeda AB, Associate Medical Director-EMEA at Baxter International, Inc., and Medical Director at Baxalta Sweden AB. Education includes a doctorate from the University of Valencia and an MBA from University Carlos III of Madrid.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/06/2026 | 25 249 ( 0,01% ) | 1 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Directeur Technique/Scientifique/R&D | - |
| Sociétés | Poste | Fin |
|---|---|---|
Takeda AB | Directeur Technique/Scientifique/R&D | 15/08/2023 |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | - |
Baxalta Sweden AB
Baxalta Sweden AB BiotechnologyHealth Technology Provides biotechnology services | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
Baxter International, Inc.
Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
University of Valencia
University of Valencia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University Carlos III of Madrid
University Carlos III of Madrid Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Takeda AB | |
Baxalta Sweden AB
Baxalta Sweden AB BiotechnologyHealth Technology Provides biotechnology services | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national